The distribution of PIG-A gene abnormalities in paroxysmal nocturnal hemoglobinuria granulocytes and cultured erythroblasts

Experimental Hematology

Volumn 29, Issue 4, 2001, Pages 391-400

  Noji, Hideyoshi ^a   Shichishima, Tsutomu ^a   Saitoh, Yurie ^a   Kai, Tatsuyuki ^a   Yamamoto, Tetsuo ^a,b   Ogawa, Kazuei ^a   Okamoto, Masatoshi ^a   Ikeda, Kazuhiko ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD16B ANTIGEN; CD59 ANTIGEN; GLYCAN; GLYCOPHORIN A; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL GLYCAN CLASS A; UNCLASSIFIED DRUG;

ACQUIRED HEMOLYTIC ANEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CASE REPORT; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL TYPE; CONTROLLED STUDY; DNA SEQUENCE; ERYTHROBLAST; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; JAPAN; MALE; NUCLEOTIDE SEQUENCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, CD55; ANTIGENS, CD59; CELL DIFFERENTIATION; CELLS, CULTURED; DNA; ERYTHROBLASTS; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; GLYCOSYLPHOSPHATIDYLINOSITOLS; GRANULOCYTES; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION; RECEPTORS, IGG; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA;

SUS SCROFA;

EID: 0035053036     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00684-6     Document Type: Article

References (71)

1. Paroxysmal nocturnal hemoglobinuria
2. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody
3. Variations in the red cells in paroxysmal nocturnal haemoglobinuria
4. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor
5. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria
6. Amino-terminal amino acid sequence and chemical and functional properties of a membrane attack complex-inhibitory factor from human erythrocyte membranes
7. CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
8. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria
9. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor
10. Structural and functional roles of glycosyl-phosphatidylinositol in membranes
11. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria
12. Heterogeneous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes
13. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis
14. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF
15. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria; usefulness for the detection of platelet antibodies
16. Mechanism of complement-mediated activation of human blood platelets in vitro
17. Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria
18. Paroxysmal nocturnal hemoglobinuria as a clonal disorder
19. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria
20. Markedly high population of affected reticulocytes negative for decay accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria
21. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay
22. Estimation of PI-bound proteins on blood cells from PNH patients by quantitative flow cytometry
23. Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells
24. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia
25. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia
26. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins
27. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lasts during erythropoiesis in vitro
28. Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria
29. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria
30. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone
31. Relationship between the phenotypes of circulating erythrocytes and cultured erythroblasts in paroxysmal nocturnal hemoglobinuria
32. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants
33. Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria
34. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria
35. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria; partial or complete defect in an early step
36. Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants
37. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis
38. Paroxysmal nocturnal hemoglobinuria; Molecular pathogenesis and molecular therapeutic approaches
39. Leukemia arising out of paroxysmal nocturnal hemoglobinuria
40. The molecular basis of paroxysmal nocturnal hemoglobinuria
41. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria
42. A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones
43. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria
44. Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria; certain immunological aspects of the hemolytic mechanism with special reference to serum complement
45. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria
46. A new monoclonal antibody (JC159) that detects glycophorin A for the diagnosis of erythroleukaemia
47. Expression of bcl-x in erythroid precursors from patients with polycythemia vera
48. Biosynthesis and function of LFA-3 in human mutant cells deficient in phosphatidylinositol-anchored proteins
49. Biological defense mechanisms; the effect of bacteria and serum on superoxide production by granulocytes
50. Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH)
51. Circulating erythropoietic precursors assessed in culture; characterization in normal men and patients with hemoglobinopathies
52. Erythroid colony formation in cultures of mouse and human bone marrow; analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-Concanavalin-A
53. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria
54. A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples
55. Characterization of genomic PIG-A gene; a gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria
56. Genomic organization of the X linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21
57. Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells
58. Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes
59. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium
60. Correction of the PNH defect by GPI-anchored protein transfer
61. Molecular basis of paroxysmal nocturnal hemoglobinuria
62. Somatic mutation and clonal selection in the pathogenesis and in the control of paroxysmal nocturnal hemoglobinuria
63. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type
64. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
65. Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria
66. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria
67. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
68. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia
69. The problem of clonality in aplastic anemia; Dr. Dameshek's riddle, restated
70. Glycosylphosphatidylinositol-anchor-deficient mice; implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria
71. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome